Top News
170 chemicals may be potential lung cancer drug targets
After testing more than 200,000 chemical compounds, UT Southwestern’s Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.
UT Southwestern experts help paralyzed college student walk again
Two years ago, a former high school athlete was at the peak of her college career when a rare autoimmune disease robbed her of her vision and the ability to walk. Today, 21-year-old Kiara Connley is making amazing progress in her recovery, after UT Southwestern neurologists identified what others missed.
Researchers identified a protein associated with breast cancer
Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies.
UT Southwestern nurses named among DFW’s Great 100 Nurses
Eight UT Southwestern Medical Center nurses are being honored at the 2018 DFW Great 100 Nurses event April 18 at the Morton H. Meyerson Symphony Center recognizing outstanding local nursing professionals.
Nephrologist to discuss journey in scaling seven summits
Dr. Biff Palmer will recount his personal mountain-climbing journey and discuss the physiologic and metabolic changes that occur at high altitudes.
FDA approves new standard of care for kidney cancer
The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer.
Why alcohol, sugar lead to thirst
UT Southwestern researchers identify a hormone that acts on the brain to increase the desire to drink water in response to specific nutrient stresses that can cause dehydration.
New treatment reduces harmful overgrowth of bacteria in IBD
More than 1.6 million Americans suffer from inflammatory bowel disease. A new strategy for treating the disease is being pursued by microbiologists at UT Southwestern Medical Center who have uncovered a novel way to control the harmful overgrowth of gut bacteria.
Pediatric cancer drug shows 93 percent response rate
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested. Read story.
Get news releases in your inbox.
Social Stories
Follow Us on social media- Juicer Feed (Facebook and Instagram)
UTSW in the News
View All UTSW in the NewsAggressive isn't always better when it comes to breast cancer
We've probably treated too many women for too long with too many drugs," said Dr. Carlos L. Arteaga, director of the Harold C. Simmons Comprehensive Cancer Center.
Watch this heart transplant surgery with a 360-degree view
UT Southwestern posted a five-minute video of a heart transplant from beginning to end. They filmed the entire thing with those 360-degree cameras.
Cancer researchers push to relax rules for clinical trials
Eighty percent of clinical trials sponsored by the US National Cancer Institute excluded people with previous cancer diagnoses.
Lurie Prize in biomedical sciences
The sixth annual Lurie Prize in Biomedical Sciences is presented to Zhijian “James” Chen, Ph.D., Professor of Molecular Biology at UT Southwestern.
More Health and Science News
View All Selected Health and Science NewsWhat’s the healthiest way to make popcorn?
“Anytime you burn fats or oils, you run the risk of creating chemical compounds that potentially can cause oxidative damage to cells,” says Lona Sandon.
How CRISPR works, explained in two minutes
You can find our latest visual attempt to wrangle the genetic complexities of CRISPR into lively, and hopefully enjoyable, two minutes.
Economic impact of medical schools and teaching hospitals
U.S. medical schools and teaching hospitals represented by the AAMC support over 6.3 million jobs in the United States.
Unnecessary exclusions shut patients out of clinical trials
Unfortunately, many sick patients are being denied the opportunity to test new drugs that might save their lives. It’s time for this to change.